Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 2Gynecologic 2Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Rectal Neoplasms 2Pancreatic Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Colorectal Neoplasms 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Enzyme-Linked Immunosorbent Assay × Gastrointestinal × Clear all
NCT01497392 2022-07-22

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

Roswell Park Cancer Institute

Phase 1 Completed
26 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01191684 2017-08-01

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

City of Hope Medical Center

Phase 1 Completed
12 enrolled
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT00895323 2013-09-17

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
9 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡